These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug interaction with coumarin anticoagulants. Kayser SR Prog Cardiovasc Nurs; 1993; 8(1):40-5. PubMed ID: 8372087 [No Abstract] [Full Text] [Related]
4. Interaction between gemfibrozil and warfarin: case report and review of the literature. Dixon DL; Williams VG Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425 [TBL] [Abstract][Full Text] [Related]
5. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease. Akin F; Yaylali GF; Bastemir M; Yapar B Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622 [TBL] [Abstract][Full Text] [Related]
6. Favourable use of non-boosted fosamprenavir in patients treated with warfarin. Honda H; Gatanaga H; Matsumura J; Kamimura M; Goto K; Tsukada K; Honda M; Teruya K; Kikuchi Y; Oka S Int J STD AIDS; 2009 Jun; 20(6):441. PubMed ID: 19451340 [No Abstract] [Full Text] [Related]
8. An evidence-based dentistry challenge: treating patients on warfarin (Coumadin). Goodchild JH; Donaldson M Dent Implantol Update; 2009 Jan; 20(1):1-8. PubMed ID: 19170364 [No Abstract] [Full Text] [Related]
9. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin. Leung VW; Shalansky SJ; Lo MK; Jadusingh EA Ann Pharmacother; 2009 May; 43(5):875-81. PubMed ID: 19401475 [TBL] [Abstract][Full Text] [Related]
10. Warfarin monitoring: consider the three Ds. Beier MT J Am Med Dir Assoc; 2005; 6(1):76. PubMed ID: 15871876 [No Abstract] [Full Text] [Related]
12. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
13. Reversal of osmolite-warfarin interaction by changing warfarin administration time. Petretich DA Clin Pharm; 1990 Feb; 9(2):93. PubMed ID: 2106407 [No Abstract] [Full Text] [Related]
14. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110 [TBL] [Abstract][Full Text] [Related]
16. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Knudsen JF; Sokol GH Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538 [TBL] [Abstract][Full Text] [Related]
17. Interaction between warfarin and tamoxifen: a case report. Mishra D; Paudel R; Kishore PV; Palaian S; Bista D; Misra P Kathmandu Univ Med J (KUMJ); 2007; 5(1):105-7. PubMed ID: 18603996 [TBL] [Abstract][Full Text] [Related]
19. Warfarin: an old drug but still interesting. Johnson JA Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378 [No Abstract] [Full Text] [Related]
20. Updated review of oral anticoagulants resistance. A case report. Alloza JL Arch Farmacol Toxicol; 1984 Apr; 10(1):45-56. PubMed ID: 6508369 [No Abstract] [Full Text] [Related] [Next] [New Search]